DR. ANED ORBEZO M.D. NPI 1841258654

NPI Information

  • NPI: 1841258654
  • Provider Name: DR. ANED ORBEZO, M.D.
  • Classification: Family Medicine - 207Q00000X
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1600 LAKELAND HILLS BLVD
    LAKELAND, FL
    ZIP 33805
  • Phone: (863) 680-7172

Map and Directions

Get Directions

NPI Details

DR. Aned Orbezo, M.D. is a family medicine in Lakeland, FL with 24 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Aned Orbezo, M.D. NPI is 1841258654. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

1600 LAKELAND HILLS BLVD
LAKELAND, FL
ZIP 33805-019
Phone: (863) 680-7172
Fax: (866) 264-8519

The NPI 1841258654 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
  • Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
  • Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
  • Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Automated urinalysis test (HCPCS:81003)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram (HCPCS:J7644)
  • Injection, furosemide, up to 20 mg (HCPCS:J1940)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Injection, ertapenem sodium, 500 mg (HCPCS:J1335)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Unclassified drugs (HCPCS:J3490)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Injection, metoclopramide hcl, up to 10 mg (HCPCS:J2765)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 5/2/2006 and was last updated on 12/13/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207P00000XEmergency Medicine00026986ALABAMANo
2207Q00000XFamily MedicineME95479FLORIDAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.